FDA Inspection 1131595 — Healthbanks Biotech USA Inc

Healthbanks Biotech USA Inc — FEI 3007390761

The FDA completed an inspection of Healthbanks Biotech USA Inc on September 25, 2020 in Irvine, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 25, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Irvine, CA (United States)